AI revolutionises ageing research: Promising anti-aging compounds

Researchers from the University of Edinburgh and the Spanish National Research Council have harnessed the power of artificial intelligence (AI) to discover three potent molecules that could potentially slow down the ageing process. The study, led by Integrated Biosciences, a biotechnology company dedicated to ageing research, demonstrates the tremendous potential of AI in uncovering novel senolytic compounds capable of suppressing age-related processes such as fibrosis, inflammation, and cancer.

AI revolutionises ageing research: Promising anti-aging compounds discovered - The Week

Applications of machine learning in computer-aided drug discovery, QRB Discovery

Advanced Aesthetics - Longevity Technology Reports

Anti-Ageing Research: Ageing in Human Cells Reversed 30 Years in New Study - Bloomberg

Figure 3 from Artificial intelligence for aging and longevity research: Recent advances and perspectives

Artificial Intelligence-Based Medical Devices Revolution in Cancer Screening: Impact into Clinical Practice

Pharmaceuticals, Free Full-Text

Identifying molecular targets for reverse aging using integrated network analysis of transcriptomic and epigenomic changes during aging

Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. - Abstract - Europe PMC

Artificial intelligence: A powerful paradigm for scientific research - ScienceDirect

Trailblazers - Longevity Technology Reports

Diagnostics, Free Full-Text

AI identifies three new antiaging senolytic candidates

AI Breakthrough in identifying senescent cells signals progress in aging and cancer therapy

Andrographolide: A Diterpenoid from Cymbopogon schoenanthus Identified as a New Hit Compound against Trypanosoma cruzi Using Machine Learning and Experimental Approaches